ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan

Irinotecan is a key drug for patients with advanced and recurrent colorectal carcinoma. However, the efficacy of irinotecan is not sufficient; partly, as there is no useful marker to predict chemosensitivity to the drug. The aim of the present study was to evaluate whether the expression levels of a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Tuy, Hoang Dinh, Shiomi, Hisanori, Mukaisho, Ken Ichi, Naka, Shigeyuki, Shimizu, Tomoharu, Sonoda, Hiromichi, Mekata, Eiji, Endo, Yoshihiro, Kurumi, Yoshimasa, Sugihara, Hiroyuki, Tani, Masaji, Tani, Tohru
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5038226/
https://ncbi.nlm.nih.gov/pubmed/27698852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4937
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados